Objective: It is known that Pseudomonas has been isolated more frequently in health care-related urinary tract infections (UTIs). It was aimed to determine the risk factors and empiric therapies due to antibiotic resistance in Pseudomonas-related male UTIs, and assess the effect of Pseudomonas isolation on treatment and length of hospital stay. Materials and Methods: The study was conducted between January 2011 and January 2013 with 228 male health care-related complicated UTI patients hospitalized in the Urology and Infectious Diseases Inpatient Clinics at Gazi University Faculty of Medicine. Three hundred UTI attacks in 228 patients were evaluated retrospectively with regard to agents. Results: Pseudomonas was isolated in 37 of 300 complicated UTI attacks in 228 male patients. Nephrolithiasis, recurrent UTI and internal urinary catheterization were determined as the risk factors for Pseudomonas related with health care-related UTI. It was understood that nephrolithiasis increased Pseudomonas isolated UTI risk 3.5 fold and recurrent UTI increased the risk 8.9 fold. The antibiotic resistance of Pseudomonas was higher than other agents. Pseudomonas related UTIs prolonged the duration of hospital stay and antibiotic treatment.
Introduction
Urinary tract infections (UTIs) constitute more than 30% of the nosocomial infections (1) . Besides causing prolonging of hospital stay and increase in health expenditures, it also leads to bacteremia and mortality in case of improper empiric therapy (2) . Therefore, it is important to determine agents early and start proper empiric therapy as soon as possible. Differentiation of increasing antibiotic resistances due to the agents requires risk factors of possible agents to be evaluated before therapy. Existence of urinary catheter, history of urological intervention, long hospital stay, male sex and existence of disease causing debility are risk factors for nosocomial UTI development (3) . Especially in recent years, non-fermenter bacteria including Pseudomonas strains have an extensive place in health carerelated infections (4) .
It was aimed to determine the risk factors and empiric therapies due to the antibiotic resistance in Pseudomonas related male UTIs, and assess the effect of Pseudomonas isolation on treatment and length of hospital stay.
Materials and Methods
The study was conducted between January 2011 and January 2013 with 228 male health care-related complicated UTI patients hospitalized in our urology and infectious diseases inpatient clinics. Three hundred UTI attacks in 228 patients were evaluated retrospectively with regard to agents. UTIs were grouped as Pseudomonas spp. isolated and not and compared for the risk factors, hospital stay and treatment duration.
Statistical Analysis
Data was presented as number and percentage and continuous variables were presented by mean ± standard deviation and median (minimum, maximum). Chi-square test was used for comparisons. Logistic regression analysis was conducted with nephrolithiasis, recurrent UTI, prostatic hypertrophy, diabetes mellitus, internal and external catheter which were determined as risk factors. Antibiotic resistance of most identified agents were determined and presented as number and percentage. Double J catheter use was accepted as internal catheterization and other urinary catheterization ways except double J catheter accepted as external catheterization.
Results
Three hundred complicated UTI attacks in 228 male patients were included. The mean age of the patients was 65.7±15.18 years (median 69; 18-94). There was no statistically significant difference between the Pseudomonas isolated and non-isolated patient groups (67±14.9 vs. 69±15.2; p=0.37).
Pseudomonas was isolated in 37 of 300 UTI attacks. Isolated agents are presented in Table 1 .
Öz
Amaç: Sağlık bakımı ilişkili üriner sistem enfeksiyonlarında (ÜSE), Pseudomonas'ın artan sıklıklarda izole edildiği bilinmektedir. Bu çalışmada, erkeklerde Pseudomonas ilişkili komplike ÜSE'de risk faktörlerinin saptanması, antibiyotik dirençleri değerlendirilerek ampirik tedavi yaklaşımlarının belirlenmesi ile Pseudomonas izolasyonunun tedavi ve hastane yatış süresi üzerine etkisinin değerlendirilmesi amaçlanmaktadır. Gereç ve Yöntem: Çalışmaya Ocak 2011-Ocak 2013 tarihleri arasında Gazi Üniversitesi Tıp Fakültesi, Üroloji ve Enfeksiyon Hastalıkları Servisleri'nde sağlık bakımı ilişkili komplike ÜSE tanısı konulan 228 erkek hasta dahil edilmiştir. Dahil edilen 228 hastada 300 ÜSE atağı izole edilen etkenler açısından retrospektif değerlendirilmiştir. Bulgular: İki yüz yirmi sekiz erkek hastada 300 komplike ÜSE atağının 37'sinde Pseudomonas izole edilmiştir. Pseudomonas ilişkili sağlık bakımı ilişkili komplike ÜSE için nefrolitiyazis, rekürren ÜSE ve internal üriner kateterizasyon risk faktörleri olarak tespit edilmiştir. Nefrolitiyazis varlığında 3,5 kat, rekürren ÜSE varlığında ise 8,9 kat riskin arttığı saptanmıştır. Pseudomonas'larda antibiyotik direncinin diğer suşlara göre daha yüksek olduğu belirlenmiştir. Pseudomonas etken olduğu ÜSE'lerin hastane yatış süreleri ve antibiyotik tedavi sürelerini uzattığı saptanmıştır. Sonuç: Sağlık bakımı ilişkili komplike ÜSE ampirik tedavisinde, nefrolitiyazis, internal üriner kateterizasyon ve rekürren ÜSE risk faktörleri varlığında Pseudomonas'a yönelik tedavinin uygun olacağı düşünülmektedir. Ampirik tedaviye yön verecek lokal antibiyotik direnç verileri göz önüne alındığında siprofloksasin kullanımın sınırlandırılması öngörülmektedir. Pseudomonas ilişkili ÜSE'lerde hastanede yatış süresi ve antibiyotik kullanım sürelerindeki artışın rekürren enfeksiyon sıklığı ve yüksek antibiyotik direnci ile ilişkili olduğu düşünülmektedir. Anahtar Kelimeler: Pseudomonas, komplike üriner sistem enfeksiyonu, ilaç direnci Table 2 .
According to the result of logistic regression analysis, it was found that recurrent UTI increased complicated UTI risk 2.97 (95% confidence interval: 1.45-6.09) fold (p=0.003).
Antibiotic resistances of most common isolated agents (Escherichia coli, Pseudomonas and Klebsiella) were determined. Ciprofloxacin resistance was 72% and 51.4% in Escherichia coli and Klebsiella isolates, respectively. Trimethoprimsulfamethoxazole resistance was 59% and 60%; extendedspectrum beta-lactamase (ESBL) positivity was 48% and 45.7%, respectively. Antibiotic resistance of Pseudomonas isolates are shown in Table 3 .
UTI attacks grouped as Pseudomonas isolated and not, compared for length of hospital stay and antibiotic treatment duration (Table 4) .
Discussion
Pseudomonas is one of the most common agents determined in complicated UTIs related with gram negative enteric bacteria and especially more often determined in health care-related UTIs (1,2,5,6,7). A study assessing the differentiation of UTI (10) found that Pseudomonas UTIs in ICU patients were associated with male gender, length of hospital stay and antibiotic therapy. A study assessing UTIs developed in males showed that the frequency of Pseudomonas originated from UTIs increase with age (11) . Urinary stone and catheter were found to be risk factor for Pseudomonas related UTI by Johansen et al. (12) . Association of bacteria except Escherichia coli with recurrent UTIs in male gender was proven in a study by Amna et al. (13) assessing community-acquired bacteriuria. A study assessing recurrent UTIs after renal transplantation found that the most common identified agent was multi-drug resistant Pseudomonas after ESBL-positive Klebsiella and ESBL-negative Escherichia coli strains (14) . In accordance with the literature, our study proved that anti-pseudomonal antibiotics should be used in empiric treatment of health care-related complicated UTIs when there are risk factors such as nephrolithiasis and recurrent UTI.
Phenotypic characteristics of Pseudomonas such as pyoverdin, protease, and phospholipase A production in combination with quorum sensing activity and biofilm formation were revealed to ease the development of catheter related UTIs (15) . In our study, internal catheter (double J catheter) presence was found to be more frequent in Pseudomonas related UTI.
Antibiotic resistance in Pseudomonas was declared to be higher than other strains in UTIs (8) . In our study, ciprofloxacin resistance was detected quite high in Pseudomonas strains and it was observed that the oral therapy chance decreased gradually. Resistance to phosphomycine which can be used in oral therapy was found in 56% of Pseudomonas strains in Turkey (16). Fu et al. (17) showed that there was 30-40% resistance to parenteral administrable anti-pseudomonal antibiotics. In our study, frequency of anti-pseudomonal cephalosporin resistance in Pseudomonas strains was detected to be 30% and higher. Also, it is known that carbapenem resistance is increasing gradually. Carbapenem resistance in Pseudomonas strains in invasive devicerelated infections was determined as 42%, 4% in a study conducted in 43 countries from Latin America, Asia, Africa and Europe (18) . In our study, carbapenem resistance was 13% in Pseudomonas which caused UTIs. Especially, a rise in recurrent infections associated with Pseudomonas causes a rise in frequency of antibiotic therapy, thereby, it easies the development of antibiotic resistance. The frequency of multi-drug resistant Pseudomonas aeruginosa in UTI was shown to be increased in half between 2000 and 2009 by Zilberberg and Shorr (19) . Clinical guidelines indicate that optimal therapy should be given according to the clinical evaluations and local antibiotic resistance data, because of the differences in data regarding resistance (20, 21) . Increases in length of hospital stay and antibiotic treatment duration were thought to be associated with recurrent infection frequency and high antibiotics resistance in Pseudomonas related UTIs.
Frequency of recurrent infection and increase in drug resistance of Pseudomonas chains make the infection treatment difficult. A study made in India showed that Pseudomonas related nosocomial UTIs increased the hospital stay duration (21) . In our study, antibiotic therapy and hospital stay duration in Pseudomonas isolated UTIs were found to be higher than in UTIs originated from other agents.
Horino et al. (22) showed that the important part of the Pseudomonas bacteremia was secondary to UTI derived from the same bacteria. Moreover, improper empiric antibiotic therapy in UTI attacks was shown to be associated with bacteremia and mortality (2).
Study Limitations
The most favorable limitation of our work is retrospective construct. It is also thought that increasing the number of agents in order to determine the risk factors for complicated UTI associated with Pseudomonas in men will increase the power of future studies. 
Conclusion
Empiric treatment should be started after assessing the risk factors of health care-related complicated UTI. Improper empiric antibiotic selection without consideration of risk factors and local resistance data in Pseudomonas related UTI especially, is thought to be the reason of recurrence and increase in resistance. Anti-pseudomonal antibiotics should be used as empiric treatment in the presence of nephrolithiasis, recurrent UTI and internal urinary catheter. However, when the resistance rates are taken into account, ciprofloxacin use should be limited. In addition, it is thought that improper empiric treatment would increase health care-related costs by prolonging hospitalization.
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